Waters Corporation WAT Biosciences — Goodwill
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Waters Corporation in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Waters Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Waters Corporation's biosciences — goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Waters Corporation's biosciences — goodwill?
- Waters Corporation (WAT) reported biosciences — goodwill of $3.8B in Q1 2026.
- What does biosciences — goodwill mean?
- This represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations specifically attributed to the Biosciences reporting segment. It reflects the premium paid for intangible assets such as brand reputation, customer relationships, and proprietary technology within the life sciences and biopharmaceutical market. Monitoring this balance is critical for assessing the long-term value of past acquisitions and potential impairment risks related to the segment's growth prospects.